Chinese healthcare firms to raise $2 billion in HK IPOs

China NT Pharma and Shanghai Pharmaceuticals aim to raise as much as $2 billion in Hong Kong IPOs this month.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES